CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang, +16

Clinical Cancer Research

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Wei Sang, Ming Shi, Jing‐Jing Yang, +26

Cancer Medicine

Enantioselective Hydrophosphination of Enones with Diphenylphosphine Catalyzed by Bis(imidazoline) NCN Pincer Palladium(II) Complexes

Xin‐Qi Hao, Yongwei Zhao, Jing‐Jing Yang, +3

Organometallics

Diphenylphosphine CatalyzedEngineeringPhebim-h LigandChemistryActive Phosphine Derivatives +15

Thermoelectrical properties of lutetium-doped Bi2Te3 bulk samples prepared from flower-like nanopowders

Jing‐Jing Yang, Fang Wu, Zheng Zhu, +3

Journal of Alloys and Compounds

Materials ScienceThermoelectrical PropertiesEngineeringFerroelectric ApplicationNanomaterials +8

Preparation and Thermoelectric Properties of Yttrium-Doped Bi2Te3 Flower-Like Nanopowders

Wenyu Shi, Fang Wu, Kunlun Wang, +3

Journal of Electronic Materials

Materials ScienceEngineeringNanomaterialsNanotechnologyThermoelectrics +3

Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika

Ruiyuan Cao, Yongfen Xu, Tianhong Zhang, +6

Open Forum Infectious Diseases

Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections

Jing‐Jing Yang, Yongfen Xu, Yunzheng Yan, +8

ACS Infectious Diseases

Hsp70 InhibitorsViral PathogenesisImmunologyMolecular BiologySmall Molecule Inhibitor +15

<scp>MDM</scp>2 is a useful prognostic biomarker for resectable gastric cancer

Ye Yang, Xuan Li, Jing‐Jing Yang, +13

Cancer Science

GastroenterologyPathologyTumor BiologyMdm2 ExpressionGastrointestinal Oncology +16

Nutrients recycle and the growth of <i>Scenedesmus obliquus</i> in synthetic wastewater under different sodium carbonate concentrations

Yun Duan, Xin Guo, Jing‐Jing Yang, +2

Royal Society Open Science

Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins

Yunzheng Yan, Jing‐Jing Yang, Xiao Dian, +17

Antiviral Research

ImmunologyPathologyZikv Viral RnaAntiviral DrugViral Structural Protein +16